These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21569292)

  • 1. Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.
    Satoh M; Krzyszczak ME; Li Y; Ceribelli A; Ross SJ; Chan EK; Segal MS; Bubb MR; Sobel ES; Reeves WH
    Arthritis Res Ther; 2011 May; 13(3):R73. PubMed ID: 21569292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.
    Krzyszczak ME; Li Y; Ross SJ; Ceribelli A; Chan EK; Bubb MR; Sobel ES; Reeves WH; Satoh M
    Clin Rheumatol; 2011 Oct; 30(10):1333-9. PubMed ID: 21523365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.
    Satoh M; Vazquez-Del Mercado M; Krzyszczak ME; Li Y; Ceribelli A; Burlingame RW; Webb TT; Sobel ES; Reeves WH; Chan EK
    Lupus; 2012 Jan; 21(1):68-74. PubMed ID: 22025191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
    Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
    Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients.
    Satoh M; Kuwana M; Ogasawara T; Ajmani AK; Langdon JJ; Kimpel D; Wang J; Reeves WH
    J Immunol; 1994 Dec; 153(12):5838-48. PubMed ID: 7989779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.
    Steen V; Domsic RT; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2012 Sep; 64(9):2986-94. PubMed ID: 22576620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality?
    Mahler M; Silverman ED; Schulte-Pelkum J; Fritzler MJ
    Autoimmun Rev; 2010 Sep; 9(11):756-60. PubMed ID: 20601198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic Differences in Autoantibody Diversity and Hierarchy: More Clues from a US Cohort of Patients with Systemic Sclerosis.
    Nandiwada SL; Peterson LK; Mayes MD; Jaskowski TD; Malmberg E; Assassi S; Satoh M; Tebo AE
    J Rheumatol; 2016 Oct; 43(10):1816-1824. PubMed ID: 27481902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA.
    Bankamp L; Preuß B; Pecher AC; Beucke N; Henes J; Klein R
    Front Immunol; 2021; 12():786039. PubMed ID: 34956217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis.
    Radić M; Martinović Kaliterna D; Ljutić D
    Clin Exp Rheumatol; 2006; 24(4):407-12. PubMed ID: 16956431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.
    Aguila LA; Lopes MR; Pretti FZ; Sampaio-Barros PD; Carlos de Souza FH; Borba EF; Shinjo SK
    Clin Rheumatol; 2014 Aug; 33(8):1093-8. PubMed ID: 24989017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of systemic sclerosis in a patient with systemic lupus erythematosus and topoisomerase I antibody.
    Katsumi S; Kobayashi N; Yamamoto Y; Miyagawa S; Shirai T
    Br J Dermatol; 2000 May; 142(5):1030-3. PubMed ID: 10809868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles.
    Tan FK; Arnett FC; Reveille JD; Ahn C; Antohi S; Sasaki T; Nishioka K; Bona CA
    Arthritis Rheum; 2000 Nov; 43(11):2464-71. PubMed ID: 11083269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-U3 RNP autoantibodies in systemic sclerosis.
    Aggarwal R; Lucas M; Fertig N; Oddis CV; Medsger TA
    Arthritis Rheum; 2009 Apr; 60(4):1112-8. PubMed ID: 19333934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Anti-Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti-Topoisomerase I-Positive Systemic Sclerosis.
    Boonstra M; Bakker JA; Grummels A; Ninaber MK; Ajmone Marsan N; Wortel CM; Huizinga TWJ; Jordan S; Hoffman-Vold AM; Distler O; Toes REM; Scherer HU; de Vries-Bouwstra JK
    Arthritis Rheumatol; 2020 Nov; 72(11):1897-1904. PubMed ID: 32840062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marker antibodies in scleroderma and polymyositis: clinical associations.
    de Rooij DJ; Van de Putte LB; Habets WJ; Van Venrooij WJ
    Clin Rheumatol; 1989 Jun; 8(2):231-7. PubMed ID: 2547546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.